Review

Rev Diabet Stud, 2011, 8(3):403-417 DOI 10.1900/RDS.2011.8.403

Fatty Heart, Cardiac Damage, and Inflammation

Maria A. Guzzardi, Patricia Iozzo

Institute of Clinical Physiology, National Research Council (CNR), Via Moruzzi 1, 56124 Pisa, Italy
Address correspondence to: Patricia Iozzo, e-mail: patricia.iozzo@ifc.cnr.it

Manuscript submitted July 25, 2011; resubmitted September 21, 2011; accepted September 27, 2011.

Keywords: type 2 diabetes, obesity, cardiovascular disease, imaging, ectopic fat, epicardial fat, lipid, lipotoxicity

Abstract

Type 2 diabetes and obesity are associated with systemic inflammation, generalized enlargement of fat depots, and uncontrolled release of fatty acids (FA) into the circulation. These features support the occurrence of cardiac adiposity, which is characterized by an increase in intramyocardial triglyceride content and an enlargement of the volume of fat surrounding the heart and vessels. Both events may initially serve as protective mechanisms to portion energy, but their excessive expansion can lead to myocardial damage and heart disease. FA overload promotes FA oxidation and the accumulation of triglycerides and metabolic intermediates, which can impair calcium signaling, β-oxidation, and glucose utilization. This leads to damaged mitochondrial function and increased production of reactive oxygen species, pro-apoptotic, and inflammatory molecules, and finally to myocardial inflammation and dysfunction. Triglyceride accumulation is associated with left ventricular hypertrophy and dysfunction. The enlargement of epicardial fat in patients with metabolic disorders, and coronary artery disease, is associated with the release of proinflammatory and proatherogenic cytokines to the subtending tissues. In this review, we examine the evidence supporting a causal relationship linking FA overload and cardiac dysfunction. Also, we disentangle the separate roles of FA oxidation and triglyceride accumulation in causing cardiac damage. Finally, we focus on the mechanisms of inflammation development in the fatty heart, before summarizing the available evidence in humans. Current literature confirms the dual (protective and detrimental) role of cardiac fat, and suggests prospective studies to establish the pathogenetic (when and how) and possible prognostic value of this potential biomarker in humans.

Fulltext: HTML , PDF (1.2 MB)


This article has been cited by other articles:

Is spinal osteophytosis associated with fatty liver?

Rozin AP, Gaitini D, Toledano K, Balbir-Gurman A

Rheumatol Rep 2012. 4(1):e4

Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients

Pietraszek A, Gregersen S, Hermansen K

Rev Diabet Stud 2011. 8(4):477-489

Physiology of incretins in health and disease

Deacon CF, Ahren B

Rev Diabet Stud 2011. 8(3):293-306

The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS Special Issue

Raz I, Gallwitz B

Rev Diabet Stud 2011. 8(3):288-292